CTMX
CytomX Therapeutics·NASDAQ
--
--(--)
--
--(--)
CTMX Filings
Filing Date
Form Description
Form Type
2026-03-26
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-26 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-19
Form 8-K - Current report
Key Events
2026-03-19 · Key Events
Form 8-K - Current report
2026-03-18
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-18 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-16
CytomX Therapeutics, Inc. (CTMX) Q4 2025 Earnings Call Transcript
Earnings Call
2026-03-16 · Earnings Call
CytomX Therapeutics, Inc. (CTMX) Q4 2025 Earnings Call Transcript
2026-03-16
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-16 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-16
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
2026-03-16 ·
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
